-
Mashup Score: 0
In this episode, hosts reflect on the advancement in CGM that reshaped care for diabetes and overall health during 2024.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Diabetes Dialouge: Tidepool Updates, with Brandon Arbiter - 1 month(s) ago
Brandon Arbiter joins the podcast to discuss the latest updates from Tidepool.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
ICYMI: The latest #DiabetesDialogue features a discussion between @DianaMIsaacs and @Natalie_Bellini with @PancreasInGame to discuss all things @Tidepool_org! https://t.co/A19hXsT66v https://t.co/J0dwLFbon8
-
-
Mashup Score: 2Diabetes Dialogue: Lingo Availability and FDA Clearance for Embecta's Tubeless Patch Pump - 3 month(s) ago
In this episode, hosts discuss availability of the Abbott Lingo CGM and Embecta’s announcement of FDA clearance for their tubeless patch pump with a 300-unit insulin reservoir.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
In the latest #DiabetesDialogue, @DianaMIsaacs and @Natalie_Bellini offer initial reactions to their experience with the Abbott Lingo—the company's first OTC CGM. Learn more: https://t.co/bzanDDH472 https://t.co/LcyO1kglWy
-
-
Mashup Score: 2Diabetes Dialogue: Lingo Availability and FDA Clearance for Embecta's Tubeless Patch Pump - 3 month(s) ago
In this episode, hosts discuss availability of the Abbott Lingo CGM and Embecta’s announcement of FDA clearance for their tubeless patch pump with a 300-unit insulin reservoir.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
In the latest #DiabetesDialogue, @DianaMIsaacs and @Natalie_Bellini offer initial reactions to their experience with the Abbott Lingo—the company's first OTC CGM. Learn more: https://t.co/bzanDDH472 https://t.co/LcyO1kglWy
-
-
Mashup Score: 2Diabetes Dialogue: Lingo Availability and FDA Clearance for Embecta's Tubeless Patch Pump - 3 month(s) ago
In this episode, hosts discuss availability of the Abbott Lingo CGM and Embecta’s announcement of FDA clearance for their tubeless patch pump with a 300-unit insulin reservoir.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
In the latest #DiabetesDialogue, @DianaMIsaacs and @Natalie_Bellini offer initial reactions to their experience with the Abbott Lingo—the company's first OTC CGM. Learn more: https://t.co/bzanDDH472 https://t.co/LcyO1kglWy
-
-
Mashup Score: 0
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The latest #DiabetesDialogue is now live! Get caught up with news in diabetes technology, including new OTC CGMs and CamAPS FX, and the renaming of JDRF to @BreakthroughT1D. https://t.co/uqzquHlfJe
-
-
Mashup Score: 0
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The latest #DiabetesDialogue is now live! Get caught up with news in diabetes technology, including new OTC CGMs and CamAPS FX, and the renaming of JDRF to @BreakthroughT1D. https://t.co/uqzquHlfJe
-
-
Mashup Score: 0
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The latest #DiabetesDialogue is now live! Get caught up with news in diabetes technology, including new OTC CGMs and CamAPS FX, and the renaming of JDRF to @BreakthroughT1D. https://t.co/uqzquHlfJe
-
-
Mashup Score: 0
This episode covers the clearance of 2 new OTC CGMs from Abbott, JDRF becoming Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with T1D
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
The latest #DiabetesDialogue is now live! Get caught up with news in diabetes technology, including new OTC CGMs and CamAPS FX, and the renaming of JDRF to @BreakthroughT1D. https://t.co/uqzquHlfJe
-
-
Mashup Score: 2Endocrinology Month in Review: March 2024 - 9 month(s) ago
In this endocrinology month in review for March 2024, we recap the most popular FDA news and pipeline updates as well as recognizing the 2-year anniversary of Diabetes Dialogue.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Need to catch up on all the endocrinology and diabetes-related headlines from March 2024? Our endocrinology month in review has you covered with a recap of FDA news, pipeline updates, and a collection of #DiabetesDialogue episodes from the last month! https://t.co/3huoL1PJEe https://t.co/TVwqPb2AN1
-
Learn all about the latest updates from @Dexcom in this recent #DiabetesDialogue: https://t.co/n9pKMVALri https://t.co/dg1EELr0e7